Tag Archives: Pfizer

Pfallergan Round II?

Posted on April 24, 2017 by

<<Trump Executive Order Could Revive Allergan-Pfizer Merger -Emily Stewart   TheStreet.com    April 22,  2017 The Trump administration’s executive order on tax regulations could revive the defunct Allergan-Pfizer merger. The White House on Friday unveiled a new executive order instructing the Treasury … Continue reading →

Posted in Big Pharma, BioFollies | Tagged , , , | 1 Comment

A Fond Farewell to My Cali-Irish Lass

Posted on April 6, 2016 by

My Dearest Allergan: The last few months have felt like a dream–you and I idling away the hours by the Irish Sea, picking out a spot for our new corporate cottage, singing the names of the staff we were going … Continue reading →

Posted in Big Pharma | Tagged , , | 2 Comments

A Thanksgiving Message from Pfallergan

Posted on November 25, 2015 by

As the United States prepares to celebrate Thanksgiving, a holiday that traditionally mixes gratitude and gluttony in relatively even proportions, we at Pfallergan would like to say how grateful we are for the fortuitous conjoining of our two constituent companies. … Continue reading →

Posted in Big Pharma | Tagged , , | Leave a comment

The Pfallergan Phallacy

Posted on November 11, 2015 by

(from NP Nov-Dec, released 10/31/15) As this issue of NP is released, the business media world is all aflutter with news that Pfizer and Allergan are discussing a merger. The headlines emphasize the massive scale of the potential alliance and … Continue reading →

Posted in Big Pharma, BioFollies | Tagged , , | Leave a comment

Pretzeled Peristalsis

Posted on May 8, 2014 by

The current spasm of M&A peristalsis just keeps yielding more data about the twisted logic so popular these days within the pharma industry and its institutional investors.Today’s sampling comes from Bloomberg.com, a piece written by Hallam and Kitamura, where they … Continue reading →

Posted in Big Pharma, BioFollies | Tagged , , , | 2 Comments

Pharma New Math: Harvard+MIT>Yale

Posted on January 15, 2013 by

The Pharma industry has no lack of leaders whose creative vision extends only to the backside of the company walking directly in front of them. Consider the latest corporate substitute for originality, the belief that location and proximity are the … Continue reading →

Posted in Big Pharma, BioFollies | Tagged , , , | Leave a comment

Pfizer Catches NextWave

Posted on October 30, 2012 by

Pfizer has acquired NextWave Pharmaceuticals, whose main asset is the recently approved Quillivant for ADHD, which is a liquid formulation of CR methylphenidate. Pfizer had optioned the company for $20 million a few months ago, another $255 million is payable … Continue reading →

Posted in Uncategorized | Tagged , , , , , | Leave a comment